The last 30 years have seen little improvement in the age-adjusted mortality rates for most common types of cancer, and until we develop more effective and less damaging treatment modalities for these tumours, selection of each patient's treatment must depend on prognostic pointers. These lead to a calculated trade off between our estimate of likely benefit to the patient, as against cost in terms of quality of life. But changes have occurred recently in our understanding of the traditional prognostic pointers used for selecting such individualised treatment. First, it is increasingly recognised that the stage at which a tumour presents is more related to the chromo logical age of the tumour (how far it has progressed before diagnosis) than to its biological characteristics. While advanced chronological age of the tumour may predict a greater likelihood of early death, only biological criteria can predict the tumour growth rate, the likelihood of prolonged survival, the likely course of the disease after the first recurrence or the likehood of response to systemic therapy. Second, there is increasing use of failure analysis in relating the clinical and biological characteristics of tumours to their response to standard treatments. In the past, the relationship was interpreted mainly in terms of survival rate, but the site and timing of first recurrence and the pattern and timing of subsequent spread provide a better assessment of the control possible from local or systemic therapy.
The last 30 years have seen little improvement in the age-adjusted mortality rates for most common types of cancer, and until we develop more effective and less damaging treatment modalities for these tumours, selection of each patient's ...
This book is all about conquering and conquering cancer. The authors wrote the book for cancer patients, survivors, caregivers, and families that they wished they had available to them when they embarked upon their cancer journey.
This book gathers up-to-date information about mesothelioma and presents it in a convenient, easily searched format, specifically intended for high compatiblity with Amazon.com's Digital Books initative and Google's Book Search.
This book will save you countless hours of research while offering you information relatively unknown by most women. Discussions include: . Factors which may contribute to breast cancer.
Discover 40 quick, useful pointers from patients who faced cancer with a positive attitude.
You may not believe in God, but you can trust the truth being shared for you in these pages. This is about using the threefold force of body, mind and spirit for the healing process. You're not going into battle alone.
The pathophysiological, epidemiological and clinical aspects of hypercalcemia of malignancy are presented in this issue, with a focus on the recently discovered humoral factor responsible for the development of hypercalcemia.
This compilation represents the first phase of a more extensive process to integrate all prognostic factors in cancer to further enhance the prediction of outcome following treatment.
This book presents an up-to-date and thorough overview of cancer of unknown primary, encompassing topics ranging from epidemiology, tumor biology, and prognostic factors through to the most recent diagnostic and therapeutic advances.
Greer, D. S., Mor, V., Morris, J. N., Sherwood, S., Kidder, D., and Birnbaum, H., An alternative in terminal care: results of the national hospice study, J. Chronic Dis., 39, 9, 1986. 50. Morris, J. N., Suissa, S., Sherwood, S. Wright, ...